{"id":"W2527243486","doi":"10.1016/j.jaad.2016.07.040","title":"Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Dermatology Life Quality Index; Placebo; Psoriasis; Janus kinase inhibitor; Quality of life (healthcare); Randomized controlled trial; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Rheumatoid arthritis; Alternative medicine; Pathology; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002360292,0.0002614177,0.003758501,0.0003099858,0.00006889048,0.00000489861,0.0003496464,0.0002151536,0.00002127817],"category_scores_gemma":[0.002231692,0.0001333687,0.0002948049,0.0002824777,0.0004785478,0.0001110981,0.000097086,0.0002706581,0.000004318574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005127614,"about_ca_system_score_gemma":0.0002154333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006438681,"about_ca_topic_score_gemma":0.00002794408,"domain_scores_codex":[0.9915935,0.004331694,0.003338834,0.0002791078,0.000115729,0.0003410761],"domain_scores_gemma":[0.9912571,0.002951765,0.005358956,0.0001961777,0.0001136222,0.000122423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9057297,0.0005692343,0.01657132,0.00002872957,0.003208826,0.000003795393,0.003207178,0.00001493908,0.03377815,0.0001272149,0.002336715,0.03442425],"study_design_scores_gemma":[0.8157367,0.001433656,0.1172428,0.0004542029,0.0005585845,0.0001238244,0.000582427,0.000001836147,0.06213063,0.0007449777,0.0005970522,0.0003933089],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763451,0.0008076908,0.00009304725,0.02086153,0.0002780417,0.0008658292,0.0007311731,0.000007637408,0.000009986752],"genre_scores_gemma":[0.9983004,0.0003739732,0.000369936,0.0008431141,0.00001989989,0.00001801367,0.00001191271,0.0000146977,0.00004807128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1006715,"threshold_uncertainty_score":0.5438618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03777943338510351,"score_gpt":0.3214798812904353,"score_spread":0.2837004479053318,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}